Study tracks COVID-19 vaccine antibody responses, identifying 'rapid-decliners' at higher risk for breakthrough infections. IgA antibodies key to respiratory protection. Personalized vaccination strategies may be needed.
New research shows mRNA HIV vaccine strategy triggers early immune responses in trials. The targeted vaccine approach represents a crucial step toward developing a protective HIV vaccine, using technology similar to COVID-19 vaccines.
Research suggests Lyme's unique peptidoglycan lingers post-treatment, triggering chronic inflammation and long-term effects. Understanding individual immune responses is crucial for better therapies. Long COVID link explored.
